Ontada
Ontada is an oncology technology and real-world data subsidiary of McKesson that provides the proprietary iKnowMed EHR, AI-powered RWD products, and provider education to community oncology providers and global life sciences companies.
- Company typePrivate
- Founded2020
- HeadquartersAtlanta, United States
- Headcount251–500
- GTM typeB2B
- OfferingSoftware
What Ontada does
Ontada is an oncology-focused technology and real-world data company that operates as a wholly-owned subsidiary of McKesson Corporation, headquartered in Boston with operations in Atlanta. The company is built on the proprietary iKnowMed electronic health record system used by over 2,800 oncology providers across The US Oncology Network, which covers 35% of community oncologists and 600+ sites of care in 35 states. On top of iKnowMed, Ontada operates the ON.Genuity AI platform and a suite of data products including ON.Journey (longitudinal EHR + claims data), ON.Multiomics (clinico-molecular cohorts with Caris Life Sciences), Genospace (NGS-based precision medicine analytics), ON.Dispensing, ON.ClinicalDataView, ON.Insights, and Alerts, alongside the Ontada Learn provider education and engagement platform and dedicated real-world research services that have supported 450+ publications.
The underlying technology stack combines an oncology-specific EHR with AI and machine learning capabilities enhanced by a Microsoft Azure OpenAI collaboration that processes over 150 million unstructured oncology document components, multiomics data, claims data, and a certified API developer program. The company's commercial offering spans point-of-care decision support, biomarker and molecular profiling integration, near-real-time dispensing and treatment alerts, longitudinal outcomes data, and provider education channels reaching more than 13,000 physicians through partnerships such as OncoPrescribe.
Ontada generates revenue primarily through enterprise subscriptions and data licensing to pharmaceutical and biotech companies (its products are used by all top 15 global life sciences companies for oncology research, commercial strategy, and HEOR), EHR licensing and related modules to community oncology practices, professional services for real-world research from proposal to publication, and provider education and engagement services delivered to life sciences sponsors. Its operating geographies are limited to the United States, with no current international footprint disclosed, and its core customers are U.S. community oncology providers and global life sciences organizations.
Ontada firmographics
Firmographics- Name
- Ontada
- Legal name
- Ontada LLC
- Website
- https://ontada.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Ontada is an oncology technology and real-world data subsidiary of McKesson that provides the proprietary iKnowMed EHR, AI-powered RWD products, and provider education to community oncology providers and global life sciences companies.
- Ownership category
- akta.pro rank
Ontada industry classification
Industry- Product category
- Oncology Real-World Data and Insights
- NAICS
- Software Publishers (513210), Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
Keywords
Where Ontada is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Ontada business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Real-World Data Solutions for Life Sciences: Ontada provides real-world oncology data solutions to pharmaceutical and life sciences companies for commercial strategy, HEOR, and research purposes. Revenue is generated through subscriptions to data products like ON.ClinicalDataView, ON.Insights, Alerts, and ON.Journey. These are typically multi-year contracts with pharmaceutical companies for access to clinical and biomarker data.
- EHR Technology Licensing: iKnowMed EHR is provided to community oncology practices within The US Oncology Network. Revenue is derived from licensing the proprietary EHR system to oncology providers.
- Provider Education Services: Ontada Learn provides digital education, practice-based education, meetings & events, and strategy services to life sciences companies seeking to engage oncology providers. This includes sponsorships, exhibits, and educational content delivery.
- Real-World Research Services: Custom research engagements from proposal to publication, supporting 450+ real-world publications. Revenue generated through research service contracts with life sciences companies and healthcare organizations.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels8 records
Ontada product offering
Product offeringCore offering
Ontada sells a proprietary oncology EHR (iKnowMed) to community oncology providers and subscription-based real-world oncology data products (ON.Journey, ON.Multiomics, ON.ClinicalDataView, ON.Insights, Alerts, ON.Dispensing, Genospace) to pharmaceutical and biotech life sciences companies. It also delivers professional real-world research services spanning proposal to publication, and provider education and engagement programs through Ontada Learn for life sciences sponsors and oncology providers.
Product overview
Ontada is an oncology technology and insights business providing a platform of integrated products and services for real-world data, research, and provider education. The core platform combines proprietary EHR technology (iKnowMed) with real-world data products (ON.Journey, ON.Multiomics, Genospace, ON.ClinicalDataView, ON.Insights, Alerts, ON.Dispensing) and the AI-powered ON.Genuity platform. Provider engagement is delivered through Ontada Learn with sub-products including Digital Education, Meetings & Events, Practice-based Education, Strategy & Effectiveness, PeerTrax, and OncoPrescribe. Point-of-care capabilities include iKnowMed EHR, mobile app, patient portal, precision medicine module, practice analytics, and Clear Value Plus. Research services support the full lifecycle from proposal to publication across 450+ publications.
Differentiator
Problem solved
Functional benefit
Brands
- Genospace: Precision medicine platform leveraging next-generation sequencing patient data to generate market reports and precision insights for oncology research.
- iKnowMed
- ON.Dispensing
- ON.Journey
- ON.Insights
- ON.ClinicalDataView
- Alerts
- ON.Multiomics
- Ontada Learn
Products and services
- iKnowMed Proprietary web-based oncology EHR built by oncologists for oncologists, providing point-of-care treatment decision support, customizable features, mobile functionality, precision medicine module, and MIPS/OCM compliance for over 2,800 oncology providers in The US Oncology Network.
- ON.Journey Longitudinal oncology real-world data product integrating iKnowMed EHR data with claims into a single standardized dataset covering 13 solid and hematologic tumor types and 150+ oncology-specific data elements for HEOR and research use.
- ON.Multiomics Translational research data product combining molecular profiling from Caris Life Sciences (whole exome sequencing, whole transcriptome sequencing, IHC across 25+ biomarkers) with longitudinal clinical data from The US Oncology Network to deliver discovery-ready, biomarker-defined patient cohorts.
- ON.Genuity AI-powered data platform combining Ontada's community oncology clinical dataset with advanced technology to generate robust, insight-rich real-world data at scale and speed.
- ON.ClinicalDataView
Quantifiable outcome
- Supported over 450+ real-world research publications
- +4 more outcomes
Companies that use Ontada
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Ontada technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability9 records
Feature8 records
Ontada partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core, flagship and minor.
- DatavantcoreOntada collaborated with Datavant to enable faster access to market-leading oncology insights. Datavant Connect powered by AWS Clean Rooms provides privacy-preserving data collaboration without underlying data movement for clinical and commercial insights.
- MicrosoftcoreOntada collaborated with Microsoft to utilize Azure AI, including Azure OpenAI Service, to process more than 150 million unstructured oncology document components. The collaboration enables delivery of quality unstructured data four times faster and provides life sciences clients more robust real-world data. Azure Batch API is leveraged for enhanced computing power and data processing at scale.
- U.S. Food and Drug Administration (FDA)flagshipOntada was awarded a competitive FDA contract to investigate the natural history of rare cancers treated in the U.S. community oncology setting. Research aims to strengthen scientific understanding leveraging Ontada's community oncology footprint and unique RWD. Goal is to enhance understanding of how patients with rare cancers present and are treated.
- Caris Life SciencescoreON.Multiomics delivers discovery-ready, biomarker-defined patient cohorts linking comprehensive molecular profiling from Caris Life Sciences (Whole Exome Sequencing, Whole Transcriptome Sequencing, IHC across 25+ biomarkers) with longitudinal clinical data from The US Oncology Network for translational research analysis.
- The US Oncology NetworkflagshipOntada's primary network partnership providing access to 35% of community oncologists across 600+ sites of care in 35 states. This partnership is foundational to Ontada's data, EHR, and provider education offerings. The US Oncology Network and McKesson Provider Solutions advance specialty care in communities where patients live.
- McKesson Precision Care Companion (PCC)coreMcKesson launched Precision Care Companion consortium bringing together oncology practices, diagnostic labs, and biopharma partners to accelerate precision medicine adoption in community oncology settings. Deployed within The US Oncology Network spanning 12 practices, focusing on lung, colon, rectal, and prostate cancers.
- White House Cancer MoonshotflagshipOntada contributed to the Enhancing Oncology Model (EOM) submission protocol for the White House Cancer Moonshot program, highlighting the company's role in combatting cancer and dedication to transforming cancer care.
- GenospacecoreGenospace, a precision medicine platform, united with Ontada to transform cancer care through biomarker-driven therapies. Genospace uses patient data from next-generation sequencing to create market reports and leverages real-world evidence for genomics in cancer progression.
- Sarah Cannon Research InstitutecoreMcKesson joint venture with Sarah Cannon Research Institute helping patients participate in cutting-edge clinical trials closer to home. Part of the broader oncology ecosystem supporting community-based oncology.
- OncoPrescribecoreExclusive partnership with OncoPrescribe makes it easier for oncologists to stay educated on changing information like biomarkers, treatment options, and disease management. Through OncoPrescribe website and weekly newsletter, reach more than 13,000 subscribers including 10,000+ physicians.
- BeiGeneminorBeiGene announced strategic alliance with Ontada in 2022 to improve U.S. community oncology care.
- MerckminorOntada signed strategic agreement with Merck in 2021 to facilitate the development of data-driven insights to impact quality of cancer care.
- AmgenminorAmgen and McKesson launched strategic agreement in 2020 to advance cancer innovation in communities.
Scale indicators19 records
Recent moves7 records
Expansion highlights6 records
Ontada competitors and assessment
Company assessmentDirect peers
- Tempus: AI-enabled precision medicine company combining multiomics (DNA/RNA sequencing) with clinical and molecular data to serve oncologists, pharma, and researchers; directly comparable as an oncology data, sequencing, and insights platform.
- COTA Healthcare: Oncology real-world evidence company that curates clinical data from EHRs for life sciences research and value-based care; directly comparable as an oncology-specific RWD/RWE vendor serving pharma and providers.
- ConcertAI: Oncology-focused real-world data and AI SaaS company serving life sciences with synthetic control arms, clinical trial design, and HEOR research; competes for the same pharma RWE engagements as ON.Journey and ON.ClinicalDataView.
- Flatiron Health: Direct peer offering oncology-specific EHR (OncoEMR) and real-world evidence to community oncology practices and life sciences; the most analogous scaled competitor to Ontada, now part of Roche, and competes head-to-head for pharma RWD budgets.
- Syapse: Real-world evidence platform focused on oncology precision medicine, integrating molecular and clinical data to support pharma decisions; competes for biomarker-defined cohort and translational RWE use cases overlapping ON.Multiomics.
Broad incumbents
- IQVIA (Oncology RWD): Global CRO and real-world data giant with oncology-specific linked data assets and EDC/CTMS offerings; overlaps with Ontada's life sciences RWE/research services as a broad incumbent rather than a niche specialist.
- McKesson Corporation: Ontada's parent company, a diversified healthcare distributor owning US Oncology Network, Sarah Cannon Research Institute, and drug distribution; comparable as the broader oncology services ecosystem within which Ontada operates and competes for adjacent spend.
Emerging players
- Guardant Health: Liquid biopsy and precision oncology company with growing real-world clinico-genomic data products for pharma and providers; overlaps with ON.Multiomics on biomarker and molecular evidence use cases for oncology drug development.
- Foundation Medicine: Roche-owned molecular profiling and genomic data company whose FoundationCore clinico-genomic database overlaps with ON.Multiomics; comparable as a clinico-molecular data partner for pharma R&D.
- Palanigo / STRATA Health Sciences: Real-world data analytics platform used by pharma and payers for treatment pattern insights; comparable as an emerging RWD analytics vendor competing for life sciences commercial and HEOR budgets adjacent to ON.Insights.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Ontada social profiles
Digital presenceOntada compliance and trust
Trust signalCompliance3 records
Ontada financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ontada leadership team
Management profileNumber of profiles
Profiles12 records
Ontada subsidiaries and ownership
Company hierarchySubsidiaries1 record
Ontada funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ontada M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ontada
What does Ontada do?
Ontada sells a proprietary oncology EHR (iKnowMed) to community oncology providers and subscription-based real-world oncology data products (ON.Journey, ON.Multiomics, ON.ClinicalDataView, ON.Insights, Alerts, ON.Dispensing, Genospace) to pharmaceutical and biotech life sciences companies. It also delivers professional real-world research services spanning proposal to publication, and provider education and engagement programs through Ontada Learn for life sciences sponsors and oncology providers.
Is Ontada a public or private company?
Ontada is a private company. It is classified as corporate owned and is currently operating.
When was Ontada founded?
Ontada was founded in 2020. It employs 251 to 500 people.
Where is Ontada based?
Ontada is headquartered in Atlanta, United States, in the North America region.
How does Ontada make money?
Four revenue lines are on record. Real-World Data Solutions for Life Sciences are the primary driver. The others are EHR Technology Licensing, provider Education Services and real-World Research Services.
Who are Ontada's main competitors?
Direct peers on record are Tempus, COTA Healthcare, ConcertAI, Flatiron Health and Syapse. Broad incumbents are IQVIA (Oncology RWD) and McKesson Corporation. Emerging players are Guardant Health, Foundation Medicine and Palanigo / STRATA Health Sciences.
Does Ontada have an API?
Yes. Ontada offers a Certified API Developer Program with self-service certification. Developers can access APIs through the API Portal to build integrations with iKnowMed. The Value Add Developer Program (by invitation) provides access to additional APIs beyond certified APIs, sandboxes, richer test data sets, and tools for workflow integration. Developers can also publish products in the Ontada Marketplace. FHIR standards are referenced for interoperability. Developer documentation is at apiaccess.mckesson.com/apiportal-service/#/login.
What industry is Ontada in?
Ontada's product category is Oncology Real-World Data and Insights. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology. Its NAICS code is 513210 and its SIC code is 8000.